Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

• Dominik Bettinger,
• Masatoshi Kudo,
• Abdul Rafeh Naqash,
• Mahvish Muzaffar,
• Thomas Marron,
• Uqba Khan,
• Myron Schwartz,
• Yi-Hsiang Huang,
• David J Pinato,
• Anwaar Saeed,
• Hannah Hildebrand,
• Yehia I Abugabal,
• Celina Ang,
• Rahul Patel,
• Edward Kim,
• Naoshi Nishida,
• Ahmed O Kaseb,
• Anjana Pillai,
• Neha Debnath,
• Antonio D'Alessio,
• Brett Marinelli,
• Mario Cedillo,
• Ishan Sinha,
• Aaron Fischman,
• Vivian Bishay,
• Max Sung

Affiliations

Dominik Bettinger

Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, Freiburg, Baden-Württemberg, Germany

Masatoshi Kudo

Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine Hospital, Osaka-Sayama, Osaka, Japan

Abdul Rafeh Naqash

Division of Cancer Treatment And Diagnosis, National Cancer Institute, Bethesda, Maryland, USA

Mahvish Muzaffar

Division of Hematology/Oncology, East Carolina University, Greenville, North Carolina, USA

Thomas Marron

3Icahn School of Medicine at Mount Sinai, New York, NY, USA

Uqba Khan

Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, Ithaca, New York, USA

Myron Schwartz

Department of Surgery, Mount Sinai School of Medicine, New York, New York, USA

Yi-Hsiang Huang

Division of Gastroenterology and Hepatology, Department of Medicine at Taipei Veterans General Hospital and Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

David J Pinato

Department of Surgery and Cancer, Imperial College London, London, UK

Anwaar Saeed

Division of Medical Oncology, Kansas University Cancer Center, Kansas City, Kansas, USA

Hannah Hildebrand

Division of Medical Oncology, Kansas University Cancer Center, Kansas City, Kansas, USA

Yehia I Abugabal

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Celina Ang

Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital School of Medicine, New York, New York, USA

Rahul Patel

Department of Trauma and Orthopaedics, University College London Hospitals NHS Foundation Trust, London, UK

Edward Kim

1 Hormones and Cancer, Cancer Genetics Laboratory, Kolling Institute, Royal North Shore Hospital, St Leonards, New South Wales, Australia

Naoshi Nishida

Faculty of Medicine Hospital, Department of Gastroenterology and Hepatology, Kindai University, Osakasayama, Japan

Ahmed O Kaseb

11 Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Anjana Pillai

Department of Medicine, New York City Health and Hospitals/ Lincoln, New York City, New York, USA

Neha Debnath

4Icahn School of Medicine at Mount Sinai, New York, USA

Antonio D'Alessio

Department of Surgery and Cancer, Imperial College London, London, UK

Brett Marinelli

Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

Mario Cedillo

Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

Ishan Sinha

Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

Aaron Fischman

Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

Vivian Bishay

Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

Max Sung

Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA